United Therapeutics Corp. (UTHR)
486.98
-9.21
(-1.86%)
USD |
NASDAQ |
Dec 31, 16:00
486.98
0.00 (0.00%)
After-Hours: 20:00
United Therapeutics Market Cap: 20.97B for Dec. 31, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Corcept Therapeutics, Inc. | 3.659B |
| Gilead Sciences, Inc. | 152.29B |
| Insmed, Inc. | 37.13B |
| Johnson & Johnson | 498.80B |
| Catalyst Pharmaceuticals, Inc. | 2.867B |
Market Cap Related Metrics
| PE Ratio | 18.46 |
| PS Ratio | 7.507 |
| PEG Ratio | 1.162 |
| Price to Book Value | 3.182 |
| Price to Free Cash Flow | 21.04 |
| Price | 486.98 |
| Earnings Yield | 5.42% |
| PEGY Ratio | 1.162 |
| Operating PE Ratio | 15.49 |
| Normalized PE Ratio | 18.25 |